Anixa Biosciences, Inc.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell te…
Biotechnology
US, San Jose [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Anixa Biosciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAnixa Biosciences, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Anixa Biosciences, Inc..
If you want to see a demo, head over to the financial segments of AAPL